Clinical trial Recruiting at 1 site Interventional Ages 18 to 60

High-Intensity Laser Therapy vs ESWT for Supraspinatus Tendinitis

Official title: Comparative Effectiveness of High-Intensity Laser Therapy Versus Extracorporeal Shock Wave Therapy in Patients With Supraspinatus Tendinitis

Run by Kafrelsheikh University · NCT07615920 · Data updated 2026-11-12

This trial tests whether high-intensity laser therapy can help shoulder pain from supraspinatus tendinitis as well as or better than extracorporeal shock wave therapy in adults.

Quick facts

Study typeInterventional
Ages18 Years to 60 Years
SexAll
Enrollment90 (estimated)
SponsorKafrelsheikh University
Academic / other
Locations1 site (Ta'if, Mecca Region)
StatusRecruiting
StartedJuly 1, 2026
Main results expectedDecember 1, 2026
Study endsJanuary 1, 2027
Registry record updatedOctober 20, 2026
Trial IDNCT07615920 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults 18–60 with ultrasound-confirmed supraspinatus tendinitis and shoulder pain lasting more than 3 months, who can consent and comply with study procedures.

Probably not a fit

Individuals with full-thickness rotator cuff tears, prior shoulder surgery, pregnancy, systemic inflammatory diseases, recent corticosteroid injections, or other ongoing physical therapy programs may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized trial compares two non-surgical treatment options for supraspinatus tendinitis: High-Intensity Laser Therapy (HILT) and Extracorporeal Shock Wave Therapy (ESWT), with a conventional physical therapy approach. Adults aged 18–60 with ultrasound-confirmed tendinitis and at least 3 months of shoulder pain are randomly assigned to receive either HILT or ESWT, with data collected on pain and function. A standard physical therapy regimen may be used as part of care, and outcomes will help determine which modality offers better symptom relief. The study is being conducted at King Faisal Medical Complex, Ta’if, with lead sponsorship by Kafrelsheikh University. Outcome measures likely include pain scores and functional assessments over a defined follow-up period.

Why it matters

Potential benefit: If successful, the trial could clarify which non-surgical therapy provides greater pain relief and function for supraspinatus tendinitis.

How similar studies have gone: Previous work in similar tendinopathy conditions shows potential benefits of both HILT and ESWT, but head-to-head data in supraspinatus tendinitis are limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Male and female participants aged between 18 and 60 years.
* Clinically diagnosed supraspinatus tendinitis confirmed by ultrasound imaging.
* Shoulder pain duration greater than 3 months.
* Ability to understand and follow study instructions.
* Willingness to participate and provide informed consent.

Exclusion Criteria:

* Full-thickness rotator cuff tear.
* Previous shoulder surgery.
* Pregnancy.
* Neurological disorders affecting the upper limb.
* Corticosteroid injection within the previous 3 months.
* Shoulder fracture or dislocation.
* Systemic inflammatory diseases.
* Participation in other physical therapy programs during the study period

Where it's running

  • King Faisal Medical Complex
    Ta'if, Mecca Region, Saudi Arabia
    Recruiting

Study contacts

  • Principal investigator: Sami ABDU Akkur, MASTER DEGREE STUDENT — Kafrelsheikh University Faculty of Physical Therapy Department of Basic Sciences for Physical Therapy
  • Study coordinator: Sami Abdu Akkur, Master
  • Email: pt.sami558@gmail.com
  • Phone: +966500433558

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.